MDL 29,913
MDL 29913 acts as selective antagonist of NK2 tachykinin receptor. It is used for the treatment of IBS.
Online Inquiry
| CAT# | R1071 |
| CAS | 135721-56-1 |
| Synonyms/Alias | 1,4,7,10,13,16-Hexaazacyclooctadecane, Cyclic Peptide Deriv.; N-(2-Amino-4-methylpentyl)-N-methyl-L-leucyl-L-glutaminyl-L-tryptophyl-L-phenylalanylglycine (5→1)-Lactam |
| M.F/Formula | C40H56N8O6 |
| M.W/Mr. | 745 |
| Sequence | QWFGLL(Modifications: Leu-5 - Leu-6 = Leu-CH2N(CH3)-Leu, Cyclized) |
| Labeling Target | NK2 tachykinin receptor |
| Appearance | White lyophilised solid |
| Purity | >97% |
| Activity | Antagonist |
| Storage | -20°C |
Solubility | Soluble in water |
InChI | InChI=1S/C40H56N8O6/c1-25(2)19-29(41)24-48(5)35(20-26(3)4)40(54)45-32(15-16-36(42)50)38(52)47-34(22-28-23-44-31-14-10-9-13-30(28)31)39(53)46-33(37(51)43-17-18-49)21-27-11-7-6-8-12-27/h6-14,17-18,23,25-26,29,32-35,44H,15-16,19-22,24,41H2,1-5H3,(H2,42,50)(H,45,54 |
InChI Key | DBIVSFCCTOEQTP-CITGXELPSA-N |
Isomeric SMILES | CC(C)CC(N)CN(C)[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc3ccccc3)C(=O)N=CC=O |
BoilingPoint | N/A |
Melting Point | N/A |
Write a review
Ask a question
My Review for MDL 29,913
Required fields are marked with *
×
Ask a Question for MDL 29,913
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
